UBS Group AG - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 23 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$11,0005,357
+6857.1%
0.00%
Q1 2022$0
-100.0%
77
-97.6%
0.00%
Q4 2021$5,0003,153
+3994.8%
0.00%
Q3 2021$0770.0%0.00%
Q2 2021$0
-100.0%
77
-96.7%
0.00%
Q1 2021$20,0002,356
+2959.7%
0.00%
Q4 2020$0
-100.0%
77
-99.9%
0.00%
Q3 2020$77,000
+3750.0%
89,804
+3462.2%
0.00%
Q2 2020$2,0002,521
+3174.0%
0.00%
Q1 2020$0770.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 181,169$259,0000.01%
CarsonAllaria Wealth Management, Ltd. 2,350$3,0000.00%
Engineers Gate Manager LP 15,428$22,0000.00%
Virtu Financial LLC 13,555$19,0000.00%
OSAIC HOLDINGS, INC. 1,602$3,0000.00%
FMR LLC 14$00.00%
US BANCORP \DE\ 2,000$3,0000.00%
WELLS FARGO & COMPANY/MN 1,682$2,0000.00%
NORTHERN TRUST CORP 42,000$60,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders